Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-08-19), GKB Ophthalmics's 9-Day RSI is 64.87.
The industry rank for GKB Ophthalmics's 9-Day RSI or its related term are showing as below:
BOM:533212's 9-Day RSI is ranked worse than 90.73% of 863
companies
in the Medical Devices & Instruments industry
Industry Median: 52.9
vs BOM:533212: 64.87
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
GKB Ophthalmics 9-Day RSI Related Terms
BOM:533212 vs ISRG, BDX, MDLN: 9-Day RSI Comparison
For the Medical Instruments & Supplies subindustry, GKB Ophthalmics's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GKB Ophthalmics 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GKB Ophthalmics's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where GKB Ophthalmics's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GKB Ophthalmics (BOM:533212) has a 9-Day RSI of 64.87 as of Aug. 19, 2026. According to the industry distribution chart, GKB Ophthalmics ranks #783 out of 863 companies in the Medical Devices & Instruments industry, placing it in the top 90.7%.
Is GKB Ophthalmics' 9-Day RSI too high?
GKB Ophthalmics' current 9-Day RSI is 64.87. The Medical Devices & Instruments industry median 9-Day RSI is 52.90. GKB Ophthalmics' value of 64.87 is 22.6% above this industry median. Based on the distribution chart, GKB Ophthalmics ranks #783 out of 863 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, GKB Ophthalmics has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' 9-Day RSI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, GKB Ophthalmics ranks #783 out of 863 companies for 9-Day RSI. This places GKB Ophthalmics in the lower half of its industry. The industry median 9-Day RSI is 52.90. GKB Ophthalmics' value of 64.87 is 22.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 52.90, based on 863 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GKB Ophthalmics's current 9-Day RSI of 64.87 is 22.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 52.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GKB Ophthalmics's current 9-Day RSI is 64.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹164.53, compared to a current price of ₹63.68 — trading 61.3% below its estimated fair value. The current 9-Day RSI is 64.87 and 22.6% above the Medical Devices & Instruments industry median of 52.90. GKB Ophthalmics' overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current 9-Day RSI is 64.87 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?
Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued.
The current stock price of ₹63.68 is trading 61.3% below its estimated GF Value™ of ₹164.53.
GuruFocus considers GKB Ophthalmics to be Significantly Undervalued.
Key valuation signals for BOM:533212:
9-Day RSI: 64.87
GF Value™: ₹164.53 vs. price of ₹63.68 (61.3% below fair value)
Industry Position: 22.6% above the Medical Devices & Instruments median (#783 of 863)
No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
53GF Score
Get the complete analysis for BOM:533212
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:533212 has been successfully added to your 
